Koru Medical Systems, Inc. insider trading
Every open-market purchase and sale by Koru Medical Systems, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Koru Medical Systems, Inc.’s insiders pay?
From March 21, 2012 to September 9, 2026, 17 insiders reported 73 open-market purchases and 4 sales not made under a pre-set plan in Koru Medical Systems, Inc. Twelve months after each purchase was reported, the shares were −79.5% against the S&P 500 on average (median −76.8%), over 7 purchases with a full year of prices; 0% beat the index. That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on September 4, 2020 into $5,148 by November 2, 2026, −10.3% a year. It held shares 21% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $16,554 (+8.6% a year), and held throughout $24,039 (+15.4%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Manko Joseph M. JR. | Director | 19 | −95.8% (1) | 0% | 1 | — | December 15, 2023 |
| Horton Capital Management, LLC | Director | 17 | −81.0% (3) | 0% | 0 | — | December 17, 2020 |
| Horton Capital Partners, LLC | Director | 11 | −94.3% (1) | 0% | 0 | — | August 22, 2023 |
| Horton Capital Partners Fund, L.P. | Director | 9 | −66.1% (1) | 0% | 0 | — | December 2, 2020 |
| Radin Arthur J | Director | 3 | — | — | 0 | — | March 5, 2019 |
| Tharby Linda M | Chief Executive Officer | 3 | — | — | 0 | — | May 20, 2026 |
| Beck James M | Director | 1 | — | — | 1 | — | June 4, 2021 |
| Fletcher R John | Director | 2 | −56.8% (1) | 0% | 0 | — | May 18, 2021 |
| Kalbermatten Adam R | Chief Commercial Officer | 2 | — | — | 0 | — | September 9, 2026 |
| Adams Thomas Edward | Chief Financial Officer | 1 | — | — | 0 | — | May 18, 2026 |
| Allen Robert T | Director | 1 | — | — | 0 | — | February 26, 2019 |
| Baker Paul Mark | Director | 0 | — | — | 1 | — | December 19, 2018 |
| Cascella Robert | Director | 1 | — | — | 0 | — | August 17, 2023 |
| Pastreich Mark L | Director | 1 | — | — | 0 | — | March 21, 2012 |
| Pazdan Christopher | Chief Operating Officer | 1 | — | — | 0 | — | May 18, 2026 |
| Schiller Eric | Chief Technology Officer | 1 | — | — | 0 | — | May 20, 2026 |
| Sealfon Andrew I | Director | 0 | — | — | 1 | — | December 19, 2018 |
When several insiders traded Koru Medical Systems, Inc.
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Koru Medical Systems, Inc. in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 1 buying crowd with six months of prices, it averaged −70.9% against the index. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| September 30, 2020 | 3 buying | −27.6% | −70.9% | −90.5% |